Search
for

    Research 10 of 1000+

    1. BEARD—A Potential Donor Site in Grade 6 and Grade 7 Alopecia: A Case Series Journal of Maxillofacial and Oral Surgery · 2021
    2. Alopecia induced by CDK 4/6 Inhibitors and its Impact on the Quality of Life of Patients with advanced Breast cancer 2025
    3. Increase in subcutaneous adipose tissue in the frontal scalp may be associated with androgenetic alopecia and metabolic syndrome. PubMed · 2023
    4. La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos Medicina Estética Revista Científica de la Sociedad Española de Medicina Estética (SEME) · 2023
    5. THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction? Dermatologic Therapy · 2010 · 9 citations
    6. 200 The relationship between the expression of cytokeratin 5/6 and clinicopathologic factors in invasive breast carcinoma Ejc Supplements · 2010
    7. Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis Expert Review of Anticancer Therapy · 2017 · 28 citations
    8. Efficacy of Platelet-rich Plasma for Treating Androgenic Alopecia of Varying Grades Clinical Drug Investigation · 2019 · 19 citations
    9. Follicular unit extraction megasession treatment of high‐grade androgenetic alopecia in Asians: Introducing novel principles for surgical design Journal of Cosmetic Dermatology · 2023
    10. A Study on Optimal Frequency and Duration of PRP in Androgenic Alopecia Saudi Journal of Medicine · 2024
    All research results →

    Learn 1 of 5

    1. Dutasteride 5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride
    All learn results →

    Community

    — no results

    Try a deeper search in community →